| | | | | | | | | | |
|
|
| Dockets Entered
On September 25, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1992N-0391
|
| Analysis of Adverse Reactions to Monosodium Glutamate (MSG)
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
| 1998P-0031
|
| Protecting America from the consequences of tobacco products
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| 2005N-0374
|
| Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers
|
|
|
| 2005P-0293
|
| Citizen Petition Regarding the Labeling of Vitamin A by Supplement Companies
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
| 2007D-0202
|
| Guidance for Industry: Microbiological Considerations for
|
|
|
| 2007N-0262
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
|
|
|
| 2007N-0264
|
| Revisions to the Requirements Applicable to Blood, Blood Components and Source Plasma, Direct Final Rule
|
|
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
| 2007P-0210
|
| Reclassification Petition for Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection under Section 513(f), 21 CFR 860 Subpart C
|
|
|
| 2007V-0360
|
| Laser Light Show
|
|
|
| 1992N-0391
|
| Analysis of Adverse Reactions to Monosodium Glutamate (MSG)
|
|
|
| C 247
|
| Carolyn Harris
|
| Vol #:
|
| 18
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
| SUP 17
|
| Chr. Hansen, Inc.
|
| Vol #:
|
| 327
|
|
|
| 1998P-0031
|
| Protecting America from the consequences of tobacco products
|
|
|
| C 3
|
| Form Letter Count 39
|
| Vol #:
|
| 1
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| CS 29
|
| FDA/DDM
|
| Vol #:
|
| 245
|
|
|
| OR 26
|
| FDA/Administrative Law Judge
|
| Vol #:
|
| 245
|
|
|
| 2005N-0374
|
| Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers
|
|
|
| C 12
|
| Thomas Burnside
|
| Vol #:
|
| 1
|
|
|
| 2005P-0293
|
| Citizen Petition Regarding the Labeling of Vitamin A by Supplement Companies
|
|
|
| C 1
|
| Jean Heister
|
| Vol #:
|
| 1
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
| C 2783
|
| J Wood
|
| Vol #:
|
| 28
|
|
|
| C 2784
|
| J Palmer
|
| Vol #:
|
| 28
|
|
|
| C 2785
|
| M Neal
|
| Vol #:
|
| 28
|
|
|
| C 2786
|
| E Pecoraro
|
| Vol #:
|
| 28
|
|
|
| C 2787
|
| A Owens
|
| Vol #:
|
| 28
|
|